In 2019, 1 in 10 (10.2%) participants of the Private Lives survey reported being daily smokers (Hill et al. 2020). This is slightly lower than the proportion of daily smokers aged 18 and over in the general Australian population (11.6%; AIHW 2020).
However, there was some variation when the proportion of daily smokers in the Private Lives Survey was examined by sexual orientation and gender:
- A higher proportion of people who identified their sexual orientation as gay (13.5%) or ‘something else’ (13%) were daily smokers. Lower proportions were reported by people who identified as asexual (3.7%), lesbian (8.3%), bisexual (8.4%), pansexual (8.8%) or queer (9.5%).
- A higher proportion of cisgender men (14.2%) were daily smokers, compared with less than 10% for cisgender women (7.7%), non-binary participants (7.9%), trans men (9.3%) and trans women (9.5%) (Hill et al. 2020).
The proportion of young people aged 14–17 years in the Writing Themselves In survey who were daily smokers (1.8%; Hill et al. 2021) was consistent with the proportion for the general Australian population aged 14–17 years (1.9%; note this estimate has a relative standard error of 25% to 50% and should be used with caution; AIHW 2020).
E-cigarettes
In 2019, higher proportions of participants of the Private Lives survey reported lifetime and current use of e-cigarettes when compared to the general Australian population aged 18 and over:
- Lifetime use – 12.9% compared to 11.4%.
- Current use – 5.7% compared to 2.6% (Hill et al. 2020; AIHW 2020).
A higher proportion of participants aged 14–17 years in the Writing Themselves In survey reported current use of e-cigarettes (4.2%; Hill et al. 2021) when compared to the general Australian population in this age range (1.8%; note this estimate has a relative standard error of 25% to 50% and should be used with caution; AIHW 2020).
Since 2010, risky drinking has been declining among people who identify as lesbian, gay or bisexual (Figure LGBTIQ1). Estimates from the NDSHS showed that from 2010 to 2019, there has been a decline in the proportion of lesbian, gay and bisexual people who exceed the guidelines for lifetime (from 30% to 22%) and single occasion risk (from 45% to 38%) for alcohol consumption (AIHW 2020).
After adjusting for age differences, people who identify as lesbian, gay or bisexual are still more likely than heterosexual people to drink at risky levels (AIHW 2020). In 2019, compared with people who identified as heterosexual, people who identified as lesbian, gay or bisexual were:
- 1.5 times as likely to exceed the lifetime risk guidelines (25% compared with 16.9%)
- 1.4 times as likely to exceed the single occasion risk guidelines at least monthly (35% compared with 26%) (AIHW 2020, Table 8.4).
- In 2019, one quarter (25%) of participants in the Private Lives survey reported drinking more than two standard drinks per day on a typical day (Hill et al. 2020). This is higher than the proportion in the general Australian population aged 18 and over who exceeded the lifetime alcohol risk guideline (17.6%; AIHW 2020).
- Higher proportions exceeding two drinks on a typical day were reported in the Private Lives survey for cisgender men (38%) and trans women (32%) and for people who identified their sexual orientation as gay (39%) or ‘something else’ (33%) (Hill et al. 2020).
- More than half (52%) of Writing Themselves In participants aged 14–17 years in 2019 reported that they never drank alcohol (Hill et al. 2021). This is substantially lower than the proportion of abstainers in the general Australian population aged 14–17 years (73%; AIHW 2020).
Unlike smoking and drinking alcohol at risky levels, recent use of illicit drugs has not declined among people who identify as lesbian, gay or bisexual between 2010 and 2019. In 2019, 2 in 5 (40%) people identifying as lesbian, gay or bisexual had recently used any illicit drug, compared with 36% in 2010 (AIHW 2020).
When adjusted for age, stability in recent drug use is relatively consistent across drug types between 2016 and 2019, with the exception of:
- non-medical use of pharmaceuticals, which fell from 12.2% in 2016 to 6.3% in 2019
- inhalants, which rose from 5.9% in 2016 to 9.9% in 2019 (AIHW 2020).
Estimates from the NDSHS show that lesbian, gay and bisexual people continue to be more likely than heterosexual people to use a range of illicit drugs (AIHW 2020). In 2019, after adjusting for age differences, 36% of people who identified as lesbian, gay or bisexual had recently used any illicit drug, compared with 16.1% of heterosexual people (AIHW 2020, Table 8.4). Compared with people who identified as heterosexual, people identifying as lesbian, gay or bisexual were:
- 9.0 times as likely to have recently used inhalants (9.9% compared with 1.1%)
- 3.9 times as likely to have recently used meth/amphetamine (5.1% compared with 1.3%)
- 3.5 times as likely to have recently used hallucinogens (4.9% compared with 1.4%)
- 2.6 times as likely to have recently used ecstasy (7.4% compared with 2.9%) (AIHW 2020, Table 8.4; Figure LGBTIQ1).
In 2019, at least 2 in 5 (44%) participants in the Private Lives survey reported using one or more drugs for non-medical purposes in the previous 6 months. The most frequently reported drugs were cannabis (30%), ecstasy/MDMA (13.9%) and cocaine (9.6%) (Hill et al. 2020). These were also the most common drugs reported for non-medical purposes in the general population (11.8% for cannabis, 4.5% for cocaine and 3.1% for ecstasy; AIHW 2020).
More than half of cisgender men (52%) and people who identified their sexual orientation as gay (51%) or queer (53%) in the Private Lives survey reported the use of drugs for non-medical purposes in the past 6 months. A higher proportion of these participants reported the use of cocaine – 14% for cisgender men and 13% each for participants who identified their sexual orientation as gay or queer. Higher proportions were reported for the use of cannabis for participants who identified their sexual orientation as bisexual (36%), pansexual (37%) or queer (38%) (Hill et al. 2020).
In 2019, over one-quarter (27%) of Writing Themselves In participants aged 14–17 years reported using any drug for non-medical purposes in the past six months. Consistent with findings from other surveys about drug use in the Australian population, the most frequently reported drug was cannabis (22%). Antidepressants (5%) followed by ecstasy (3.3%) were the next most common reported drugs for non-medical purposes (Hill et al. 2021).
More than 3 in 10 trans men (34%), cisgender men (33%), trans women (31%) and participants who identified their sexual orientation as queer (32%) in the Writing Themselves In survey reported the use of drugs for non-medical purposes in the past six months (Hill et al. 2021).
Injecting drug use
For related content on injecting drug use, see also:
Responses from the 2021 Australian Needle Syringe Program Survey (ANSPS) show that 4% of respondents identified as homosexual and 10% as bisexual (Heard et al. 2022).
Data collection for the 2021 ANSPS was impacted by COVID-19 restrictions. The survey took place in several phases from September to December 2021, instead of the usual October timeframe. Victoria and NSW experienced outbreaks between June and November 2021, resulting in a reduction in the amount of participating NSP services. This should be considered when comparing data from 2020 with previous years (Heard et al. 2022).
Treatment
The majority (66%) of participants in the Private Lives 3 survey who sought professional support for their drug use did so from a mainstream service. Four in ten (40%) sought support from a mainstream service known to be LGBTIQ-inclusive and 8% from a service that caters only to lesbian, gay, bisexual, transgender and/or intersex people (Hill et al. 2020).